Health

CMS's CRUSH rule reaches past Medicare into Molina's $42 billion Medicaid book

The November 18 rout priced the proposal as a UnitedHealth-Humana Medicare bill. Molina is leaving that business, so for it the rule's weight falls on the Medicaid audit duties covering the $42 billion premium book that carries its $9.50 2027 earnings framework.

Richard TangRichard Tangthree-minute read
Share
Dr. Mehmet Oz, in a dark suit and red tie, photographed outdoors in sunlight
Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, at the Great American State Fair in Washington on June 29, 2026, where he was a speaker. His agency issued the CRUSH proposed rule on November 16.

The market traded the new proposal from the Centers for Medicare & Medicaid Services, the federal insurer's regulator, as a Medicare Advantage bill: Humana−1.52% — Humana, down 1.52 percent today and UnitedHealth−4.64% — UnitedHealth, down 4.64 percent today, the two names most exposed to that business, fell hardest on November 18 12. Molina Healthcare−1.71% — Molina Healthcare, down 1.71 percent today joined the rout, down 5.1 percent on November 17, giving back the 8 percent jump it had scored on a delay to Medicaid work requirements 13.

But Molina's earnings run through Medicaid, and the parts of the rule that reach a Medicaid insurer are the audit and repayment duties. The selloff sorted the industry by Medicare exposure; for Molina, the risk sits in the other book.

The rout punished Medicare Advantage exposure hardest

Humana and UnitedHealth, the most Medicare Advantage exposed, fell double digits

-15%-10%-5%0%Humana-12.7%UnitedHealth-10.2%CVS Health-5.2%Cigna-3.4%
Data
Value
Humana-12.7%
UnitedHealth-10.2%
CVS Health-5.2%
Cigna-3.4%
One-day change on November 18, 2026, percent; Cigna's figure is a late-session reading. Cigna sold its Medicare Advantage business in 2025. Source: BeInsure.1

The clawback looks back to 2018; the audit duties run forward

CRUSH, short for Comprehensive Regulations to Uncover Suspicious Healthcare, was issued November 16 45. It would extrapolate the findings of risk-adjustment audits, which check the medical records behind a plan's payments, from a sample across an entire Medicare Advantage contract, back to payment year 2018, with no fee-for-service adjuster, the discount that used to shrink such recoveries 45. CMS expects that to recover about $9 billion a payment year, inside nearly $90 billion of projected federal savings from 2027 to 2036 4. It is a proposal, not a final rule 2.

For Medicaid plans the work is reporting and repayment

For Medicaid insurers the rule does quieter work. Managed-care plans would report beneficiary deaths and address changes within 30 days and return the tied overpayments, and self-identified Medicaid fee-for-service overpayments would come back within 60 days 4. Beneficiary eligibility audits would move under direct federal oversight 4. CMS calls CRUSH a standalone, discretionary rule rather than an annual payment rule, then adds that it intends to conduct program-integrity rulemaking of this kind annually going forward 4.

The clawback touches Molina's past; the audits touch its future

Molina exits general-issue Medicare Advantage, the standard individual plans, after 2026, keeping the members eligible for both Medicare and Medicaid 6. Its Medicare contracts from 2018 through 2026 would, on the rule as drafted, sit inside the clawback's reach 4; what the market values from here is the $42 billion premium book its Medicaid-heavy model runs on 6.

Nine-fifty a share assumes the loss ratio gets no better

On that book sits the framework for at least $9.50 of 2027 earnings that finance chief Mark Keim laid out at an investor conference last week 67: it assumes no improvement in a Medicaid loss ratio, the share of premium dollars spent on medical care, guided at 92.6 percent for this year. The rule's machinery questions exactly those records: who is enrolled, who moved, who died 4. A recovery built on zero slippage now faces a regulator reading the same files.

Molina's margin on premium has fallen by a third since mid-2024

6%8%10%12%14%Q3 '24Q1 '25Q3 '25Q1 '26Q3 '2692.6% loss ratio guide implies 7.4%7.8%
Data
Gross margin
Q2 '2412.3%
Q3 '2411.5%
Q4 '2410.6%
Q1 '2511.5%
Q2 '2510.2%
Q3 '258.1%
Q4 '256.2%
Q1 '269.5%
Q2 '268.5%
Q3 '267.8%
Gross margin, the share of revenue left after medical costs, by quarter, percent. Molina's 2026 guidance implies a 92.6 percent medical loss ratio, a 7.4 percent margin, and the $9.50 framework assumes that ratio gets no better. Source: Molina Healthcare quarterly figures from its SEC filings [10].10

Molina is already suing the agency that wrote the rule

Molina is already fighting the agency: it has sued CMS over 2027 star ratings, Medicare's plan-quality scores, which it says cost it $140 million, Modern Healthcare reported 8. It is also shedding the pieces that lose money, leaving Illinois's ACA exchange, the Obamacare marketplace, for 2027 as shoppers there face fewer insurers and lowest-cost plans running 10 to 14 percent higher 9.

Comments close in January; the guide lands in February

The contrarian case has a real leg, because the clawback's centerpiece lands in Medicare books Molina has decided to leave; its thinner leg is the Medicaid one. Two dates settle the argument. Comments close on January 19, 2027 15, and what survives into the final rule shows how much of the extrapolation and the 30-day duties are real. Molina guides in February 6, and that number shows whether the recovery still stands.

Get Health by email, free

AI in medicine, pharma and biotech. In our daily email, every weekday.

Loading HUM

Reader comments

0 comments

    More in Health

    All in this topic →

    Health

    Eli Lilly Agreed to Buy Calytrix Bio for Up to $1.5 Billion, Its Latest Deal in a $32 Billion Year

    A $32 billion acquisition year rests on an $11 billion quarterly cash engine, but the deal headlines are "up to" figures and the balance sheet is already thinning. Whose money moves: anyone holding LLY at 31 times forward earnings into December 7 and January.

    Health

    GE HealthCare's manganese MRI agent matched gadolinium, a route past China's rare earths

    About 65 million contrast-enhanced MRI scans a year run on gadolinium, a rare earth whose export China licenses. A manganese substitute that matched the incumbent in GE HealthCare's Phase 2 trial opens a route off that chain for the company's highest-margin segment, if Phase 3 holds.

    Health

    Abridge lost AI scribing to Microsoft and Epic; its next market has a $100 million price from Wolters Kluwer

    Microsoft and Epic took two of every three new AI-scribe dollars this year, and Abridge, which built that market, is selling what comes after the note. The decision-support category it is moving into just got a public price, Wolters Kluwer's $100 million AgileMD deal, and that price is what Abridge's $6.69 billion private mark has to outrun.

    Health

    AstraZeneca commits $200 million to Tempus AI through 2031 but can walk away for the shortfall

    A five-year, $200 million renewal from AstraZeneca gives Tempus AI a revenue floor it can book, filed days before a shareholder vote on a stock-funded acquisition, but the contract lets the drugmaker quit early by paying only the shortfall.

    Health

    OpenEvidence CEO tells medical students to take paper exams as OpenAI and Anthropic give doctors AI free

    Daniel Nadler built a $15 billion company on giving doctors AI answers free. On Monday he warned the doctors still training on his tool that AI erodes the skill that makes an answer worth having.

    Health

    Molina Healthcare jumps 8% on a CMS work-rule delay; director Steven Orlando sold 702 shares at $227.33

    A CMS work-rule delay bought Molina's Medicaid book time, not margin, and insiders including director Steven Orlando sold into the strength. New buyers are paying roughly 24 times a 2027 framework that is not yet guidance and must still be earned in February.

    Subscribe to TheInference for free